日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Neoadjuvant immune checkpoint blockade before chemoradiation for cervical squamous carcinoma (GINECO window-of-opportunity COLIBRI study): a phase II trial

宫颈鳞状细胞癌新辅助放化疗前免疫检查点阻断治疗(GINECO 机会窗口 COLIBRI 研究):一项 II 期试验

Ray-Coquard, Isabelle; Kaminsky-Forrett, Marie-Christine; Ohkuma, Ryotaro; de Montfort, Aymeric; Joly, Florence; Treilleux, Isabelle; Ghamry-Barrin, Sarah; Bello-Roufai, Diana; Saintigny, Pierre; Angelergues, Antoine; Michon, Lucas; Hardy-Bessard, Anne-Claire; Attignon, Valéry; Auclair, Jessie; Chemin, Gabriel; Lainé, Alexandra; Péré, Hélène; Veyer, David; Savoye, Aude-Marie; Berthet, Justine; Caux, Christophe; Lecuru, Fabrice; Dubois, Bertrand; Bétrian, Sarah

Correction: Tumor Akkermansia muciniphila predicts clinical response to immune checkpoint inhibitors in non-small-cell lung cancer patients with low PD-L1 expression

更正:肿瘤 Akkermansia muciniphila 可预测 PD-L1 低表达的非小细胞肺癌患者对免疫检查点抑制剂的临床反应

Shimizu, Takashi; Ohkuma, Ryotaro; Homma, Mayumi; Nakayama, Shingo; Sasaki, Yosuke; Muto, Satoshi; Ieguchi, Katsuaki; Watanabe, Makoto; Taguchi, Akashi; Takayanagi, Daisuke; Wada, Youichiro; Horiike, Atsushi; Kubota, Yutaro; Ariizumi, Hirotsugu; Shimokawa, Masahiro; Hirasawa, Yuya; Ishiguro, Tomoyuki; Suzuki, Risako; Iriguchi, Nana; Mura, Emiko; Yoshimura, Kiyoshi; Tsuji, Mayumi; Kiuchi, Yuji; Suzuki, Hiroyuki; Yamochi, Toshiko

Tumor Akkermansia muciniphila predicts clinical response to immune checkpoint inhibitors in non-small-cell lung cancer patients with low PD-L1 expression

肿瘤阿克曼菌(Akkermansia muciniphila)可预测PD-L1低表达的非小细胞肺癌患者对免疫检查点抑制剂的临床反应

Shimizu, Takashi; Ohkuma, Ryotaro; Homma, Mayumi; Nakayama, Shingo; Sasaki, Yosuke; Muto, Satoshi; Ieguchi, Katsuaki; Watanabe, Makoto; Taguchi, Akashi; Takayanagi, Daisuke; Wada, Youichiro; Horiike, Atsushi; Kubota, Yutaro; Ariizumi, Hirotsugu; Shimokawa, Masahiro; Hirasawa, Yuya; Ishiguro, Tomoyuki; Suzuki, Risako; Iriguchi, Nana; Mura, Emiko; Yoshimura, Kiyoshi; Tsuji, Mayumi; Kiuchi, Yuji; Suzuki, Hiroyuki; Yamochi, Toshiko

Vinegar intake in patients undergoing immune checkpoint inhibitor therapy: food frequency questionnaire study

接受免疫检查点抑制剂治疗的患者醋摄入量:食物频率问卷调查研究

Ariizumi, Hirotsugu; Shimazui, Miyuki; Ogawa, Chisato; Kaneki, Mika; Saito, Nanaho; Mura, Emiko; Suzuki, Risako; Tsurui, Toshiaki; Iriguchi, Nana; Ishiguro, Tomoyuki; Hirasawa, Yuya; Shimokawa, Masahiro; Ohkuma, Ryotaro; Kubota, Yutaro; Horiike, Atsushi; Wada, Satoshi; Yoshimura, Kiyoshi; Murakami, Kouzou; Tsunoda, Takuya

Veillonella and Streptococcus are associated with aging of the gut microbiota and affect the efficacy of immune checkpoint inhibitors

韦荣氏球菌和链球菌与肠道菌群老化有关,并影响免疫检查点抑制剂的疗效。

Hirasawa, Yuya; Isobe, Junya; Hosonuma, Masahiro; Tsurui, Toshiaki; Baba, Yuta; Funayama, Eiji; Tajima, Kohei; Murayama, Masakazu; Narikawa, Yoichiro; Toyoda, Hitoshi; Shida, Midori; Sasaki, Aya; Maruyama, Yuuki; Amari, Yasunobu; Mura, Emiko; Suzuki, Risako; Iriguchi, Nana; Ishiguro, Tomoyuki; Ohkuma, Ryotaro; Shimokawa, Masahiro; Ariizumi, Hirotsugu; Kubota, Yutaro; Horiike, Atsushi; Sambe, Takehiko; Uchida, Naoki; Wada, Satoshi; Kobayashi, Shinichi; Kiuchi, Yuji; Kuramasu, Atsuo; Yoshimura, Kiyoshi; Tsunoda, Takuya

Inosine shapes PD-1 blockade responses and synergizes with dual PD-1/CTLA-4 immunotherapy to enhance antitumor immunity

肌苷可调控PD-1阻断反应,并与PD-1/CTLA-4双重免疫疗法产生协同作用,从而增强抗肿瘤免疫力。

Narikawa, Yoichiro; Kuramasu, Atsuo; Hosonuma, Masahiro; Murayama, Masakazu; Funayama, Eiji; Sasaki, Akiko; Baba, Yuta; Toyoda, Hitoshi; Isobe, Junya; Tajima, Kohei; Nakashima, Rie; Sasaki, Aya; Maruyama, Yuki; Yamazaki, Yoshitaka; Shida, Midori; Tsurui, Toshiaki; Hirasawa, Yuya; Ariizumi, Hirotsugu; Ishiguro, Tomoyuki; Suzuki, Risako; Ohkuma, Ryotaro; Kubota, Yutaro; Sambe, Takehiko; Tsuji, Mayumi; Wada, Satoshi; Horiike, Atsushi; Kobayashi, Shinichi; Tsunoda, Takuya; Kobayashi, Sei; Kobayashi, Hitome; Oguchi, Tatsunori; Shimane, Toshikazu; Kiuchi, Yuji; Yoshimura, Kiyoshi

Plasma WFDC2 (HE4) as a Predictive Biomarker for Clinical Outcomes in Cancer Patients Receiving Anti-PD-1 Therapy: A Pilot Study

血浆WFDC2(HE4)作为接受抗PD-1治疗的癌症患者临床结局的预测性生物标志物:一项初步研究

Watanabe, Makoto; Ieguchi, Katsuaki; Shimizu, Takashi; Ohkuma, Ryotaro; Suzuki, Risako; Mura, Emiko; Iriguchi, Nana; Ishiguro, Tomoyuki; Hirasawa, Yuya; Ikeda, Go; Shimokawa, Masahiro; Ariizumi, Hirotsugu; Yoshimura, Kiyoshi; Horiike, Atsushi; Tsunoda, Takuya; Tsuji, Mayumi; Kobayashi, Shinichi; Oguchi, Tatsunori; Kiuchi, Yuji; Wada, Satoshi

Eosinophils and the Efficacy of Immune Checkpoint Inhibitors Across Multiple Cancers: A Retrospective Study

嗜酸性粒细胞与免疫检查点抑制剂在多种癌症中的疗效:一项回顾性研究

Suzuki, Risako; Ohkuma, Ryotaro; Watanabe, Makoto; Mura, Emiko; Tsurui, Toshiaki; Iriguchi, Nana; Ishiguro, Tomoyuki; Hirasawa, Yuya; Ikeda, Go; Shimokawa, Masahiro; Ariizumi, Hirotsugu; Kubota, Yutaro; Yoshimura, Kiyoshi; Kobayashi, Shinichi; Tsunoda, Takuya; Horiike, Atsushi; Tsuji, Mayumi; Kiuchi, Yuji; Oguchi, Tatsunori; Wada, Satoshi

Evaluation of patient immunocompetence for immune checkpoint inhibitor therapy using the psoas muscle index: a retrospective cohort study

利用腰大肌指数评估患者免疫检查点抑制剂治疗的免疫功能:一项回顾性队列研究

Tsurui, Toshiaki; Hamada, Kazuyuki; Mura, Emiko; Suzuki, Risako; Iriguchi, Nana; Ishiguro, Tomoyuki; Hirasawa, Yuya; Ohkuma, Ryotaro; Shimokawa, Masahiro; Ariizumi, Hirotsugu; Kubota, Yutaro; Horiike, Atsushi; Wada, Satoshi; Yoshimura, Kiyoshi; Tsuji, Mayumi; Kiuchi, Yuji; Tsunoda, Takuya

Elevated plasma levels of WAP four-disulfide core domain 2 as a potential prognostic biomarker for various cancers.

血浆中 WAP 四二硫键核心结构域 2 水平升高可作为多种癌症的潜在预后生物标志物

Watanabe Makoto, Ieguchi Katsuaki, Onishi Nobuyuki, Shimizu Takashi, Ohkuma Ryotaro, Suzuki Risako, Mura Emiko, Iriguchi Nana, Ishiguro Tomoyuki, Hirasawa Yuya, Ikeda Go, Shimokawa Masahiro, Ariizumi Hirotsugu, Horiike Atsushi, Yoshimura Kiyoshi, Tsunoda Takuya, Tsuji Mayumi, Kobayashi Shinichi, Kiuchi Yuji, Wada Satoshi